Akums Drugs and Pharmaceuticals, a contract development and manufacturing organisation (CDMO) based in India, has been awarded European Good Manufacturing Practice (EU GMP) certificates for two of its manufacturing facilities in Haridwar, Uttarakhand.
The approvals, issued by the Bulgarian Drug Agency, are valid for three years through October 2028 and align the facilities with EU-regulated quality standards.
The certification for Plant 1 represents the renewal of its existing EU GMP status and allows the facility to manufacture and supply tablets, hard gelatin capsules and sachet dosage forms for markets that recognise EU-GMP compliance. The approval for Plant 2 is a new certification, authorising the production and supply of oral liquid formulations for these same markets.
With both facilities now compliant with EU-GMP norms, Akums plans to leverage the fresh approval for Plant 2 to support a €200 million contract in the European market and pursue new business opportunities in the EU and other regions that follow EU-GMP standards.
The quality clearances are expected to strengthen Akums’ ability to serve regulated export markets, reinforce long-term industry partnerships and support the company’s broader global growth strategy by expanding its footprint in highly regulated pharmaceutical supply chains.
Also Read